Zura Bio (NASDAQ: ZURA) investors approve board slate, auditor and 2023 equity plan changes
Rhea-AI Filing Summary
Zura Bio Limited held its Annual General Meeting of Shareholders on June 17, 2026, where a quorum was present. Shareholders approved an amendment and restatement of the company’s 2023 Equity Incentive Plan, which became effective immediately upon approval.
All eight director nominees were elected to serve until the next annual general meeting or earlier departure. Shareholders also ratified the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for the fiscal year ending December 31, 2026. Because the director slate, auditor ratification and equity plan proposals all received sufficient support, the contingency proposal to adjourn the meeting was not submitted for a vote.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 5.07, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Equity plan approval votes for: 38,850,373 votes
Equity plan votes against: 17,403,607 votes
Equity plan broker non-votes: 18,267,509 votes
+4 more
7 metrics
Equity plan approval votes for
38,850,373 votes
For amended and restated 2023 Equity Incentive Plan
Equity plan votes against
17,403,607 votes
Against amended and restated 2023 Equity Incentive Plan
Equity plan broker non-votes
18,267,509 votes
Broker non-votes on equity plan proposal
Auditor ratification votes for
74,323,697 votes
For ratification of WithumSmith+Brown, PC
Auditor ratification votes against
30,527 votes
Against ratification of WithumSmith+Brown, PC
Director example votes for
56,209,068 votes
For election of director nominee Mark Eisner
Director example votes against
291,173 votes
Against election of director nominee Daniel Becker
Key Terms
Equity Incentive Plan, ordinary resolution, independent registered public accounting firm, Broker Non-Votes, +1 more
5 terms
Equity Incentive Plan financial
"approved an amendment and restatement of the Company’s 2023 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
ordinary resolution regulatory
"the election, by ordinary resolution, of the eight (8) directors listed below"
An ordinary resolution is a decision made by shareholders at a company meeting that is approved when more than half of the votes cast are in favor. Think of it like a household vote where a majority decides routine matters — it covers everyday corporate actions such as approving directors, routine policy changes, or distributions, and matters to investors because these majority-approved choices shape governance, management authority, and the company’s near-term direction.
independent registered public accounting firm regulatory
"the appointment by the Audit Committee of the Board of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Broker Non-Votes financial
"For | | Against | | Abstain | | Broker Non-Votes 38,850,373"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
Which directors were elected to ZURA’s board at the 2026 annual meeting?
Shareholders elected Daniel Becker, Mark Eisner, Jennifer Jarrett, Sandeep Kulkarni, Amit Munshi, Ajay Nirula, Steven Schoch and Parvinder Thiara as directors, each to serve until the next annual general meeting or earlier departure.
Was the proposal to adjourn ZURA’s 2026 annual meeting used?
No. The adjournment proposal was not put to a vote because the director elections, auditor ratification and the amended 2023 Equity Incentive Plan were all approved by the requisite number of shareholder votes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
